Viral safety of plasma-derived medicinal products with respect to hepatitis E virus

Current version

PDF iconReflection paper

Reference numberEMA/CHMP/BWP/723009/2014
Published27/06/2016
KeywordsHepatitis E virus, plasma-derived products, blood infectivity
DescriptionThis document addresses the viral safety of plasma-derived medicinal products with respect to hepatitis E virus. It discusses HEV reduction by specific manufacturing steps and risk assessment for these products.


Document history

First version

Current version

PDF iconReflection paper


PDF iconOverview of comments


PDF iconDraft reflection paper


PDF iconConcept paper

Published: 27/06/2016


Published: 27/06/2016


Published: 01/07/2015


Published: 24/07/2008


Related content


How useful was this page?

Add your rating